Neuroinflammation and mitochondrial dysfunction, key mechanisms in the pathogenesis of Parkinson's disease (PD), are usually explored independently. Loss-of-function mutations of PARK2 and PARK6, encoding the E3 ubiquitin protein ligase Parkin and the mitochondrial serine/threonine kinase PINK1, account for a large proportion of cases of autosomal recessive early-onset PD.
2016 Program), Grant/Award Number: ID 12095; Grant Sponsor: GIS-Institut de maladies rares inflammasome complex formation. Enhanced NLRP3 signaling in Parkin-deficient cells was accompanied by a lack of induction of A20, a well-known negative regulator of the NF-jB pathway recently shown to attenuate NLRP3 inflammasome activity. We also found an inverse correlation between A20 abundance and IL-1b release, in human macrophages challenged with NLRP3 inflammasome inducers. Overall, our observations suggest that the A20/NLRP3-inflammasome axis participates in the pathogenesis of PARK2-linked PD, paving the way for the exploration of its potential as a biomarker and treatment target. (McLelland, Soubannier, Chen, McBride, & Fon, 2014; Narendra, Tanaka, Suen, & Youle, 2008; Pickrell & Youle, 2015; Sayre, 1989) . The neuroinflammation observed in PD is characterized by excessive microglial cell activation, supported by histological findings from post-mortem examinations and recent positron emission tomography imaging of the brain (Halliday & Stevens, 2011; Hirsch & Hunot, 2009) . Moreover, high levels of proinflammatory cytokines have been observed in the brain and cerebrospinal fluid of patients compared with controls (Hirsch & Hunot, 2009 ).
Molecular patterns associated with invading organisms or released during degenerative processes (danger-associated molecular patterns, DAMPs) bind to specific receptors, including those of the NOD-like receptor (NLR) family, thereby activating signaling cascades that promote pathogen elimination and tissue repair. The NLR family member NLRP3 and its intracellular signaling complex, the inflammasome, play a broad role in various inflammatory conditions (Gross, Thomas, Guarda, & Tschopp, 2011; Lee, Kang, Lee, & Jo, 2013) . They have recently been linked to the pathogenesis of Alzheimer's disease (AD), and are suspected to contribute to neurodegeneration in PD (Codolo et al., 2013; Heneka et al., 2013; Sarkar et al., 2017; Yan et al., 2015) The NLRP3 inflammasome is activated, in a two-step mechanism, in response to DAMP stimuli, including amyloid beta-oligomers and a-synuclein (Codolo et al., 2013; : (1) a priming step mediated by TLR and the nuclear translocation of NF-jB (nuclear factor-kappa B), associated with the transcriptional induction of NLRP3 and the immature forms of the proinflammatory cytokines interleukin (IL)-1b and IL-18 and (2) an activation step, during which NLRP3 and its adaptor ASC (apoptosis-associated speck-like protein containing a CARD) assemble into a complex at the endoplasmic reticulum-mitochondrion interface (Martinon, Burns, & Tschopp, 2002; Rossol et al., 2012) . This complex recruits and activates caspase-1, leading to the processing and release of IL-1b and IL-18 (Latz, Xiao, & Stutz, 2013) . Regulatory negative feedback loops operate in immune cells, both at the transcriptional level and at the level of NLRP3 complex formation and stability, to prevent overactivation of the NLRP3 inflammasome (Guarda et al., 2009; Mishra et al., 2013; Walle et al., 2014) .
Mitochondria have recently emerged as a platform for the shaping of innate immune responses, including in the context of NLRP3-dependent signaling (Shimada et al., 2012; R. Zhou, Yazdi, Menu, & Tschopp, 2011) . Mitochondrial quality control (MQC) plays a key role in attenuating this pathway, by preserving a cohort of functional mitochondria within the cell (Lazarou, 2015; Zhong et al., 2016) . Several studies have linked Parkin and PINK1 to innate immunity (Greene, Whitworth, Andrews, Parker, & Pallanck, 2005; Matheoud et al., 2016; Torres-Odio et al., 2017) . A loss of PARK2 function increases susceptibility to mycobacterial infection and sensitivity to inflammation-related dopaminergic (DA) neuron degeneration (Chopra et al., 2014; FrankCannon et al., 2008; Lazarou, 2015; Manzanillo et al., 2013; Mira et al., 2004) , while the expression of PARK2 and PINK1 is stimulated by hepatitis viruses (Khan, Syed, Kim, & Siddiqui, 2016) . Parkin regulates the NF-jB-dependent inflammatory pathway (Henn et al., 2007) , and Parkin deficiency enhances the production of cytokines, such as TNFa, IL-6 and monocyte chemoattractant protein-1 (MCP-1; de L es eleuc et al., 2013; Tran et al., 2011) .
In this study, we explored the link between MQC impairment and neuroinflammation in PD further, by investigating the response of PARK2-and PINK1-deficient primary microglial cells to proinflammatory stimuli and dissecting the impact of Parkin and PINK1 dysfunction on NLRP3 inflammasome signaling. We found that a loss of PARK2 function exacerbated inflammasome activation by attenuating a negative feedback loop restricting NLRP3 inflammasome activity, in both primary murine immune cells and primary macrophages from patients with PARK2 mutations. These results suggest that the NLRP3-inflammasome participates in the pathogenesis of PD as a result of PARK2 dysfunction, paving the way for the exploration of this complex as a target for disease prevention and treatment. Patients (n 5 6, Table 1 ) and control subjects (5) gave written informed consent for blood assessment. Primary human macrophages were differentiated from peripheral blood mononuclear cells (PBMCs) obtained from fresh blood samples by stimulation with recombinant human GM-CSF (Peprotech, Neuilly-sur-Seine, France), and cultured as previously described (Xue et al., 2014) . PBMCs were isolated by Ficoll (Histopaque, Sigma Aldrich, L'Isle d'Abeau Chesnes, France) density gradient centrifugation from freshly collected blood (40 ml). After several centrifugations, the PBMC layer was transferred to a CD14 1 magnetic microbeads column (Miltenyi, Bergisch Gladbach, Germany) and purified with the Miltenyi Monocyte Isolation Kit to obtain a suspension highly enriched in monocytes.
| Mice
Animals were housed in an accredited animal facility. They were handled, and cared for in accordance with French and European regulations on animal research and the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The experiments were approved by the animal facility board of directors, the Institute's Welfare Committee and Comit e d'Ethique pour l'exp erimentation animale Charles Darwin. Park2 2/2 mice were generated and brought into the C56Bl/6j genetic background as previously described (Damiano et al., 2014; Itier et al., 2003 ) and WT mice were generated by intercross of heterozygous Park2 1/2 (or Pink1 1/2 ) mice.
| Isolation of microglial cells
Microglial cultures were prepared from the brains of postnatal day 1 mouse pups, as previously described (Sepulveda-Diaz et al., 2016) .
Whole brains were harvested, the meninges were stripped away and brain tissue pieces were placed in 4 ml of Leibovitz's L-15 medium (Invi- A mixture of SoAdvanced Universal SYBR Green Supermix (Biorad), primers (0.5 mM) and cDNA (1 ml) was used for the reaction. Fold-change differences in expression were calculated with REST software. 1 The data for each gene listed in Table 2 were normalized relative to the expression of the housekeeping gene, PPIA.
| Immunoblot analyses and ELISA assays
Cell extracts were homogenized in radioimmunoprecipitation assay 
| Immunofluorescence staining
Cells were washed in PBS, fixed by incubation with 4% paraformaldehyde (Sigma Aldrich) for 20 min and permeabilized by incubation in 0.2% Triton X-100 (Sigma Aldrich) in PBS for 10 min. Non-specific antibody binding was blocked by incubation in PBS containing 10% normal (Fetz, Knauer, Bier, von Kries, & Stauber, 2009) . One common step in our analyses was the adjustment of the assay protocol, through the modification of several parameters, to ensure optimal object identification, including background correction, the setting of a threshold of pixel definition derived from the Hoechst signal and object segmentation parameters. This step optimized object identification, making it possible to exclude irregular "non-cellular" objects automatically and to quantify various cell parameters rapidly in thousands of cells. We then used the following arrayscan protocols: "Spot detector" (mitochondrial marker, A20 aggresomes), "General measurement intensity" (IBA1, NLRP3 and A20 fluorescence levels). Confocal microscopy was performed with a Leica Sp7 confocal microscope (Leica, Wetzlar, Germany). MetaMorph software (Roper Scientific, Ottobrun, Germany) was used for image acquisition
| Statistical analyses
Statistical analyses were performed with Prism 6 (Graph Pad Software).
Pooled results are expressed as means 6 SEM. 
| Loss of Park2/Pink1 function exacerbates NLRP3 inflammasome activation by specific inducers
We investigated whether the increase in IL-1b and IL-18 production in Park2 2/2 microglia following LPS exposure was due to overactivation of the NLRP3 inflammasome. We used the small molecule MCC950 to inhibit NLRP3-dependent responses selectively, without affecting inflammasome complexes dependent on other innate immune receptors, such as AIM2, NLRC4 and NLRP1 (Coll et al., 2015) . We also used a classical two-signal model for direct activation of the NLRP3 inflammasome, based on exposure to LPS for 3 hr (signal I) followed by exposure to microbial toxin, nigericin, or ATP for 2 hr (signal II), to promote K 1 efflux from the cell, leading to caspase 1 activation and pro-IL-1b/ IL-18 processing and release into the extracellular space (Cullen, Kearney, Clancy, & Martin, 2015; Munoz-Planillo et al., 2013) .
Microglial cells exposed to LPS-nigericin or LPS-ATP released massive amounts of IL-1b and IL-18, 10 times and twice higher, respectively, than the amounts released in response to LPS alone (Figure 2a ) Nigericin and ATP also strongly increase NLRP3 levels and caspase 1 cleavage in WT cells, as revealed by immunocytochemistry (c and d) and immunoblotting (e-g; n 5 6). All these parameters are significantly exacerbated in Park2 2/2 microglia (n 5 6). n is the number of independent experiments. Error bars indicate the SEM. *p < .05, **p < .01, ***p < .001. # versus corresponding untreated control (UT) unless otherwise indicated. Scale bars: 10 mm F IGURE 3.
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| 1743 (Scaffidi, Misteli, & Bianchi, 2002) . In cells treated with ATP or nigericin, HMGB1 release is dependent on activation of the NLRP3 inflammasome and caspase 1 (Lu et al., 2012) . We therefore performed an automated immunofluorescence-based quantitative analysis of the nuclear localization of HMGB1 in different conditions, to obtain an indirect estimate of the nucleocytoplasmic translocation and release of this molecule. As expected, following LPS-nigericin/-ATP treatment, HMGB1 was translocated to the cytoplasm in both WT and Park2 2/2 microglial cells.
(Supporting Information Figure S1 ). Consistent with our previous observations suggesting that the NLRP3 inflammasome is overactivated in the absence of Parkin, translocation levels were higher in Park2 2/2 cells than in WT cells.
We investigated whether the loss of PINK1 function affected microglial responses in a similar way to PARK2 dysfunction, by repeating these analyses in PINK1-deficient microglial cells. We again observed an overactivation of the NLRP3 inflammasome after exposure to LPS-nigericin, as illustrated by caspase 1 cleavage (Supporting Information Figure S2a ,b) and the levels of IL-1b release (Supporting Information Figure S2d ). However, these changes were not accompanied by a significant increase in NLRP3 levels (Supporting Information Figure   S2a ,c,e,f).
| The loss of PARK2/PINK1-dependent MQC abolishes the attenuation of NLRP3 inflammasome activation in microglial cells
The Parkin-dependent mitophagy induced by NF-jB in response to NLRP3-activating stimuli was recently shown to restrict NLRP3 activation (Zhong et al., 2016) . We therefore reinvestigated the possibility of a link between NLRP3 inflammasome overactivation in microglial cells and plays a key role in attenuating NLRP3 inflammasome activity (Duong et al., 2015; Walle et al., 2014) . A well-characterized mechanism underlying the negative feedback regulation of the NLRP3 experiments. The error bars indicate the 6SEM. *p < .05, **p < .01, ***p < .001. # versus corresponding untreated control (UT) unless otherwise indicated. Scale bars: 10 mm inflammasome by A20 involves the inhibition of NF-jB activation and NF-jB-dependent gene expression (Beyaert, Heyninck, & Van Huffel, 2000 ; Figure 4b ). In our experimental conditions, A20 protein levels in WT cells increased by a factor of more than four following exposure to LPS-nigericin, as revealed by immunoblotting and confirmed by immunofluorescence approaches (Figure 4c,d ). This increase was associated with the appearance of intracellular A20-positive punctate bodies, previously reported to correspond to insoluble aggresomes in which A20
F IGURE 4.
MOUTON-LIGER ET AL.
| 1745 sequesters inflammatory intermediates required for NF-jB signaling (Enesa, Moll, Luong, Ferran, & Evans, 2015) . The upregulation of A20 protein levels was accompanied by an upregulation of TNFAIP3 expression following exposure to LPS-nigericin, as indicated by the quantitative analysis of transcript levels (Figure 4e ). A20 induction was significantly attenuated, at both the transcript and protein levels, in the absence of Parkin (Figure 4c-e) , suggesting that PARK2 dysfunction impairs the transcriptional regulation of A20. PINK1 deficiency or the treatment of cells with 3-MA had no effect on Tnfaip3 mRNA levels or inflammasome components in response to treatment with LPSnigericin, indicating that this regulation does not involve mitophagy (Figure 4a ,e,f).
| The NLRP3-inflammasome is overactivated in immune cells from PD patients with PARK2 mutations
We investigated the relevance of the NLRP3 inflammasome deregula- Similarly, the increase in A20 levels observed in WT BMDMs subjected to proinflammatory stimuli was attenuated in Park2 2/2 cells (Supporting Information Figure S4c,e) .
We then analyzed these responses in primary human bloodderived macrophages obtained from control individuals (n 5 5) and PD patients with PARK2 mutations (n 5 6). Macrophages from control subjects displayed significant activation following exposure to LPSnigericin or LPS-ATP, which strongly induced the NLRP3 inflammasome, as shown by the analysis of intracellular NLRP3 levels and IL-1b production ( Figure 5a,b,d ). This activation was exacerbated in macrophages from patients with PARK2 mutations, as shown by the higher levels of NLRP3 immunofluorescence and IL-1b and the tendency towards higher levels of IL18 release than for cells from control individuals (Figure 5a,b,d,e) . It was also associated with a lower abundance of the A20 protein (Figure 5c ). Linear regression analysis revealed a significant inverse correlation between A20 abundance and the amounts of IL-1b released, in human macrophages treated with LPSnigericin or LPS-ATP (Figure 5f,g ).
| D ISC USSION
The cooperation between PINK1 and Parkin in MQC mechanisms, ranging from the removal of damaged mitochondrial components to the degradation of whole dysfunctional organelles by mitophagy, has been studied in detail (McLelland et al., 2014; Mouton-Liger, Jacoupy, Corvol, & Corti, 2017; Narendra et al., 2008; Pickrell & Youle, 2015) . Immunofluorescence staining for NLRP3 and A20 in primary macrophages from control subjects (n 5 5) and PD patients with PARK2 mutations (n 5 6; a), with the corresponding quantifications. NLRP3 levels are significantly higher in PARK2 macrophages treated with LPS 1 nigericin than in control cells (b), whereas the induction of A20 is weaker (c). (d and e) ELISA revealed significantly higher levels of IL-1b release from PARK2 macrophages (n 5 6) than from control cells (n 5 5).
(f and g) Graphic representation illustrating the significant inverse correlation between A20 levels and levels of IL-1b (d) and IL-18 (e) released from macrophages of controls and patients, treated with LPS-nigericin (f) or LPS-ATP (g). n is the number of independent experiments. The error bars indicate the SEM. *p < .05, **p < .01, ***p < .001. # versus corresponding untreated control (UT) unless otherwise indicated. Scale bars: 10 mm neurodegeneration induced by the mitochondrial neurotoxin MPTP (Yan et al., 2015) . These observations highlight the potential relevance of the NLRP3 inflammasome to PD pathogenesis. Together with the acknowledged role of this complex in AD (Heneka et al., 2013) or ALS (Amyotrophic lateral sclerosis; Johann et al., 2015) , these findings support a more general role, extending beyond inflammatory disorders in neurodegenerative diseases. Remarkably, overactivation of the NLRP3 inflammasome was recently identified as the cause of the greater susceptibility to polymicrobial sepsis-induced organ failure and death in Pink1 2/2 and Park2 2/2 mice, in which it has also been linked to lower DA levels (Kang et al., 2016) .
Recent studies have demonstrated a role for Parkin-dependent mitophagy in limiting NLRP3 activation in peripheral macrophages and primary fibroblasts (Sumpter et al., 2016; Zhong et al., 2016 However, our study highlights another mechanism underlying NLRP3 inflammasome deregulation in Parkin-deficient cells. This mechanism involves the well-known negative regulator of the NF-jB pathway, A20 (Beyaert et al., 2000) , the loss of which was recently shown to lead to NLRP3 inflammasome overactivation in vitro and in vivo, in a model of chronic autoinflammatory rheumatoid arthritis (Duong et al., 2015; Walle et al., 2014) . We show here that A20 mRNA and protein (George et al., 2017) . This is consistent with other observations highlighting PINK1-independent functions of Parkin (Johnson, Charan, & LaVoie, 2012) : (1) Parkin can rescue phenotypes linked to loss-of-function mutations in pink1 in Drosophila models (Dodson & Guo, 2007) ; (2) Parkin inactivates Bax, regulating cytochrome c release and stress-induced apoptosis independently of PINK1 (Berger et al., 2009; Johnson, Berger, Cortese, & Lavoie, 2012) ; and (3) Parkin targets phagosomes containing mycobacteria for ubiquitin-mediated autophagic removal, but there is no evidence for the presence of PINK1 on such phagosomes (Manzanillo et al., 2013) .
Overall, our results place Parkin at the crossroads of innate immune pathways relating to the three major families of pattern recognition receptors. The roles of Parkin in Toll-like receptors (TLR)/NF-jB (de Leseleuc et al., 2013; Frank-Cannon et al., 2008; Tran et al., 2011) and RIG-I-like receptors (RLR)/MAVS signaling have already been reported (Khan et al., 2016 ), but we highlight here the role of this protein in the NLR inflammasome pathway. Our study also raises questions about the more general role of the A20 regulatory pathway and its role in modulating the strength of NLRP3 inflammasome activity in patients with sporadic PD. Analyses of these pathways may help to identify subgroups of PD patients with an inflammasome overactivation profile, an essential step towards the development of targeted treatments. One recent study reported a decrease in A20 mRNA levels in the blood of PD patients (Perga et al., 2017) similar to that reported in chronic inflammatory diseases (Gilli et al., 2011) , supporting the potential use of A20 as a biomarker. During the last decade, the NLRP3 inflammasome has emerged as a promising pharmacological target for the prevention and treatment of a number of immune-related diseases, including cancer, type II diabetes, rheumatoid arthritis and AD (Çimen et al., 2016; Coll et al., 2015; Lamkanfi & Dixit, 2012; White, Lawrence, Brough, & Rivers-Auty, 2017) . Strategies for controlling inflammasome activity are already being considered in clinical trials for some of these disorders, and might, if successful, be extended to subgroups of PD patients presenting aberrant NLRP3 signaling. 
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